Key result
Review outlines diagnosis, risk stratification, and management of non-peripartum cardiomyopathies in pregnancy.
Why the study?
Cardiomyopathies in pregnancy are uncommon but potentially life-threatening, and their diagnosis and management require specific considerations distinct from peripartum cardiomyopathy.
This review summarizes the diagnosis, risk stratification, medical management, and peripartum care for various non-peripartum cardiomyopathies during pregnancy.
Guides preconception counseling and peripartum planning for non-peripartum cardiomyopathies; leaves open need for prospective validation of strategies.
Cardiomyopathies are uncommon but potentially life-threatening causes of cardiovascular disease in pregnancy. Pregnancy-associated hemodynamic changes may reveal unrecognized cardiomyopathy or exacerbate existing myocardial dysfunction. This review summarizes the diagnosis and management of dilated cardiomyopathy, hypertrophic cardiomyopathy, left ventricular hypertrabeculation/noncompaction cardiomyopathy, Takotsubo cardiomyopathy, and other rare cardiomyopathies during pregnancy. Our discussion will include pregnancy-specific hemodynamic considerations, risk stratification, medical management, labor and delivery planning, postpartum surveillance, and counseling regarding future pregnancy. This review does not address peripartum cardiomyopathy because it is considered separately.
No takes yet. Share an insight, caveat, or question.
Behnia et al. (2026) conducted a review in Cardiomyopathies in pregnancy. This review provides an overview of the diagnosis, risk stratification, and management of various cardiomyopathies during pregnancy, excluding peripartum cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: